{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:38:20Z","timestamp":1774388300584,"version":"3.50.1"},"reference-count":71,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Multiple sclerosis (MS) and migraine are neurological diseases, affecting young women. Migraine is the most prevalent type of headache in people with MS (pwMS). Objectives: The aim of this review is to describe the clinical, radiological, and therapeutic features of MS and migraine comorbidity. The clinical section focuses on the characteristics of migraine in pwMS and of MS in co-occurrence with migraine, and on the presence of other possible comorbidities. The radiological section deals with the differential diagnosis of white matter lesions and changes in connectivity patterns on brain magnetic resonanceto investigate a possible link between MS and migraine. The therapeutic section evaluates the effects of MS-disease-modifying therapies on migraine and of prophylactic migraine treatments on MS. Methods: The literature search was conducted using PubMed as an electronic database. The papers that reported relevant clinical, radiological and therapeutic findings were selected. Results: Among 1351 results retrieved, at the end of screening procedures, 34 studies were selected. Migraine can impact the perception of some symptoms and the presence of some comorbidities, particularly relevant in MS. Furthermore, migraine and MS share some radiological features, leading to diagnostic challenges, however identifying some lesion characteristics and changes in the connectivity pathway may be supportive. Medications for migraine and MS should be administered considering both the adverse events and multiple drug interactions. Conclusions: The data emerging from this review illustrate the research efforts aimed at providing valuable insights into accurate diagnosis, effective clinical management, and the definition of targeted treatment schedules that could improve the quality of life for pwMS with migraine.<\/jats:p>","DOI":"10.3390\/jcm14020561","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T12:27:54Z","timestamp":1737030474000},"page":"561","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Insights and Radiological Features on Multiple Sclerosis Comorbid with Migraine"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3672-2526","authenticated-orcid":false,"given":"Maddalena","family":"Sparaco","sequence":"first","affiliation":[{"name":"2nd Division of Neurology, University Hospital of Campania Luigi Vanvitelli, Via Sergio Pansini, 5, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-9720","authenticated-orcid":false,"given":"Simona","family":"Bonavita","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0404.1982.tb06856.x","article-title":"Age at onset, initial symptomatology and the course of multiple sclerosis","volume":"66","author":"Poser","year":"1982","journal-title":"Acta Neurol. Scand."},{"key":"ref_2","unstructured":"(2018). Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38, 1\u2013211."},{"key":"ref_3","unstructured":"GBD (2024). 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet, 403, 2133\u20132161."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e01830","DOI":"10.1002\/brb3.1830","article-title":"The epidemiology of primary headaches in patients with multiple sclerosis","volume":"11","author":"Wang","year":"2021","journal-title":"Brain Behav."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104954","DOI":"10.1016\/j.msard.2023.104954","article-title":"The association between multiple sclerosis and migraine: A meta-analysis","volume":"79","author":"Mohammadi","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocn.2020.06.021","article-title":"The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis","volume":"79","author":"Mirmosayyeb","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10194-010-0237-9","article-title":"Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course","volume":"11","author":"Kister","year":"2010","journal-title":"J. Headache Pain"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"M\u00f6hrke, J., Kropp, P., and Zettl, U.K. (2013). Headaches in multiple sclerosis patients might imply an inflammatorial process. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069570"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00702-018-1959-0","article-title":"Headache in the course of multiple sclerosis: A prospective study","volume":"126","author":"Gebhardt","year":"2018","journal-title":"J. Neural Transm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e1353","DOI":"10.1212\/WNL.0000000000206791","article-title":"Cross-Trait Mendelian Randomization Study to Investigate Whether Migraine Is a Risk Factor for Multiple Sclerosis","volume":"100","author":"Horton","year":"2023","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.1526-4610.2009.01427.x","article-title":"Frequency of chronic headaches in Japanese patients with multiple sclerosis: With special reference to opticospinal and common forms of multiple sclerosis","volume":"49","author":"Doi","year":"2009","journal-title":"Headache"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.msard.2018.09.022","article-title":"Headache characteristics in multiple sclerosis","volume":"27","author":"Beckmann","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1468-2982.2004.00790.x","article-title":"Prevalence of primary headaches in people with multiple sclerosis","volume":"24","author":"Rigamonti","year":"2004","journal-title":"Cephalalgia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1590\/0004-282x20190100","article-title":"Migraine in 746 patients with multiple sclerosis","volume":"77","author":"Fragoso","year":"2019","journal-title":"Arq. Neuropsiquiatr"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10072-010-0443-x","article-title":"The use of ID migraine\u2122 questionnaire in patients with multiple sclerosis","volume":"32","author":"Villani","year":"2011","journal-title":"Neurol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0317167100028523","article-title":"Vascular headache: A presenting symptom of multiple sclerosis","volume":"16","author":"Freedman","year":"1989","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105602","DOI":"10.1016\/j.msard.2024.105602","article-title":"Prevalence of primary headaches in multiple sclerosis patients","volume":"86","author":"Naseer","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.msard.2015.07.014","article-title":"CIHR Team in the Epide-miology and Impact of Comorbidity on Multiple Sclerosis (ECoMS). Comorbidity is associated with pain-related activity limi-tations in multiple sclerosis","volume":"4","author":"Fiest","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nicl.2015.07.013","article-title":"Increased contrast enhancing lesion activity in relapsing\u2013remitting multiple sclerosis migraine patients","volume":"9","author":"Graziano","year":"2015","journal-title":"NeuroImage Clin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1007\/s10072-011-0519-2","article-title":"Quality of life of multiple sclerosis patients with comorbid migraine","volume":"32","author":"Villani","year":"2011","journal-title":"Neurol Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101946","DOI":"10.1016\/j.msard.2020.101946","article-title":"Why do multiple sclerosis and migraine coexist?","volume":"40","author":"Say","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/brain\/awz144","article-title":"Assessment of lesions on magnetic resonance imaging in multiple sclerosis: Practical guidelines","volume":"142","author":"Filippi","year":"2019","journal-title":"Brain"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Dobrynina, L.A., Suslina, A.D., Gubanova, M.V., Belopasova, A.V., Sergeeva, A.N., Evers, S., Gnedovskaya, E.V., and Krotenkova, M.V. (2021). White matter hyperintensity in different migraine subtypes. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-90341-0"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.291.4.427","article-title":"Migraine as a risk factor for subclinical brain lesions","volume":"291","author":"Kruit","year":"2004","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-2982.2009.01904.x","article-title":"Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA study","volume":"30","author":"Kruit","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/1352458512471874","article-title":"Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients","volume":"19","author":"Liu","year":"2013","journal-title":"Mult. Scler. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1739","DOI":"10.1212\/WNL.0000000000007266","article-title":"How much do periventricular lesions assist in distinguishing migraine with aura from CIS?","volume":"92","author":"Lapucci","year":"2019","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jocn.2011.07.044","article-title":"Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis","volume":"19","author":"Kamson","year":"2012","journal-title":"J. Clin. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s00415-012-6571-x","article-title":"Patients with migraine do not have MRI-visible cortical lesions","volume":"259","author":"Absinta","year":"2012","journal-title":"J. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/acn3.273","article-title":"\u201cCentral vessel sign\u201d on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine","volume":"3","author":"Solomon","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lapucci, C., Tazza, F., Rebella, S., Boffa, G., Sbragia, E., Bruschi, N., Mancuso, E., Mavilio, N., Signori, A., and Roccatagliata, L. (2023). Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1084661"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"John, F., Kis-Jakab, G., Kom\u00e1romy, H., Perlaki, G., Orsi, G., Bosny\u00e1k, E., Rozgonyi, R., Trauninger, A., Eklics, K., and Kamson, D.O. (2024). Differentiation of hemispheric white matter lesions in migraine and multiple sclerosis with similar radiological features using advanced MRI. Front. Neurosci., 18.","DOI":"10.3389\/fnins.2024.1384073"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1007\/s00415-020-09923-z","article-title":"BOLD signal within and around white matter lesions distinguishes multiple sclerosis and non-specific white matter disease: A three-dimensional approach","volume":"267","author":"Sivakolundu","year":"2020","journal-title":"J. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/jmri.24580","article-title":"Differentiating white matter lesions in multiple sclerosis and migraine using monoexponential and biexponential diffusion measurements","volume":"41","author":"Orsi","year":"2015","journal-title":"J. Magn. Reson Imaging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1526-4610.2005.05136.x","article-title":"The association of brainstem lesions with migraine-like headache: An imaging study of multiple sclerosis","volume":"45","author":"Gee","year":"2005","journal-title":"Headache"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jns.2006.01.015","article-title":"Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis","volume":"244","author":"Tortorella","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Pravat\u00e0, E., Riccitelli, G.C., Sestieri, C., Sacco, R., Cianfoni, A., Gobbi, C., and Zecca, C. (2021). Migraine in Multiple Sclerosis Patients Affects Func-tional Connectivity of the Brain Circuitry Involved in Pain Processing. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.690300"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.59.4.636","article-title":"Interferon beta but not glatiramer acetate therapy aggravates headaches in MS","volume":"59","author":"Erasmus","year":"2002","journal-title":"Neurology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1191\/1352458506ms1298oa","article-title":"Interferon treatment may trigger primary headaches in multiple sclerosis patients","volume":"12","author":"Rigamonti","year":"2006","journal-title":"Mult. Scler. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1212\/WNL.0000000000004037","article-title":"Evaluating the safety of \u03b2-interferons in MS: A series of nested case-control studies","volume":"88","author":"Kingwell","year":"2017","journal-title":"Neurology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2147\/JPR.S230680","article-title":"Interferon-beta-induced headache in patients with multiple sclerosis: Frequency and characterization","volume":"13","author":"Elmazny","year":"2020","journal-title":"J. Pain. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1526-4610.2012.02146.x","article-title":"The impact of interferon beta and natalizumab on comorbid migraine in multiple sclerosis","volume":"52","author":"Villani","year":"2012","journal-title":"Headache"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Mavridis, T., Papagiannakis, N., Breza, M., Vavougios, G.D., Patas, K., Daponte, A., Laskaratos, A., Archontakis-Barakakis, P., Panta-zopoulos, I., and Mitsikostas, D.D. (2022). B-Cell Targeted Therapies in Patients with Multiple Sclerosis and Incidence of Headache: A Sys-tematic Review and Meta-Analysis. J. Pers. Med., 12.","DOI":"10.3390\/jpm12091474"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1007\/s10072-022-06197-3","article-title":"Comparative safety of high-efficacy disease-modifying therapies in relaps-ing-remitting multiple sclerosis: A systematic review and network meta-analysis","volume":"43","author":"Kawalec","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.msard.2019.06.036","article-title":"Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis","volume":"35","author":"Lucchetta","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1177\/13524585221096353","article-title":"Anti-CGRP therapies for migraine in multiple sclerosis patients","volume":"28","author":"Bose","year":"2022","journal-title":"Mult. Scler."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11940-014-0323-4","article-title":"Treatment of mood disorders in multiple sclerosis","volume":"17","year":"2015","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_50","unstructured":"(2024, June 28). Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/gilenya-epar-product-information_en.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Bensmail, D., Karam, P., Forestier, A., Loze, J.-Y., and L\u00e9vy, J. (2023). Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study. Toxins, 15.","DOI":"10.3390\/toxins15040280"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/20494637211014544","article-title":"The efficacy of botulinum toxin type-A for intractable chronic migraine patients with no pain-free time","volume":"16","author":"Atraszkiewicz","year":"2022","journal-title":"Br. J. Pain"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7224\/1537-2073.2023-013","article-title":"Use of Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Migraines in Individuals With Multiple Sclerosis","volume":"26","author":"Mason","year":"2024","journal-title":"Int. J. MS Care"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"102489","DOI":"10.1016\/j.msard.2020.102489","article-title":"Smartphone based behavioral therapy for pain in multiple sclerosis (MS) patients: A fea-sibility acceptability randomized controlled study for the treatment of comorbid migraine and ms pain","volume":"46","author":"Minen","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00415-019-09426-6","article-title":"Psychiatric disorders in multiple sclerosis","volume":"268","author":"Sparaco","year":"2021","journal-title":"J. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10194-010-0282-4","article-title":"Migraine and psychiatric comorbidity: A review of clinical findings","volume":"12","author":"Antonaci","year":"2011","journal-title":"J. Headache Pain"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1111\/ene.14697","article-title":"Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID-19 pandemic","volume":"28","author":"Bonavita","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Sparaco, M., and Bonavita, S. (2024). Vitamin D Supplementation: Effect on Cytokine Profile in Multiple Sclerosis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13030835"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s10072-019-04021-z","article-title":"Vitamin D in migraine headache: A comprehensive review on literature","volume":"40","author":"Ghorbani","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10072-019-04220-8","article-title":"Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: A randomized clinical trial","volume":"41","author":"Ghorbani","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_61","unstructured":"Montalban, X. Revised McDonald Criteria 2023, Presented at Scientific Session 1: New Diagnostic Criteria, ECTRIMS 2024."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1212\/WNL.59.1.72","article-title":"Functional MRI-BOLD of brainstem structures during visually triggered migraine","volume":"59","author":"Cao","year":"2002","journal-title":"Neurology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0306-4522(01)00303-7","article-title":"The periaqueductal grey matter modulates trigeminovascular input: A role in migraine?","volume":"106","author":"Knight","year":"2001","journal-title":"Neuroscience"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/brain\/awh295","article-title":"Hyperexcitability of the primary somatosensory cortex in migraine\u2014A magnetoencephalographic study","volume":"127","author":"Lang","year":"2004","journal-title":"Brain"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.21746","article-title":"Propagation of Spreading Depression Inversely Correlates with Cortical Myelin Content","volume":"66","author":"Merkler","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbrc.2010.11.115","article-title":"Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants","volume":"404","author":"Dawson","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Faustmann, T.J., Wawrzyniak, M., Faustmann, P.M., Corvace, F., and Ismail, F.S. (2023). Inhibition of Microglial Activation by Amitriptyline and Doxepin in Interferon-\u03b2 Pre-Treated Astrocyte\u2013Microglia Co-Culture Model of Inflammation. Brain Sci., 13.","DOI":"10.3390\/brainsci13030493"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"104584","DOI":"10.1016\/j.msard.2023.104584","article-title":"Pain and cognitive performance in adults with multiple sclerosis: A systematic review","volume":"71","author":"Brown","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000500094","article-title":"Propranolol Impairs Primary Immune Responses in Rat Ex-perimental Autoimmune Encephalomyelitis","volume":"26","year":"2019","journal-title":"Neuroimmunomodulation"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Pilipovi\u0107, I., Stoji\u0107-Vukani\u0107, Z., Priji\u0107, I., Jasni\u0107, N., and Leposavi\u0107, G. (2020). Propranolol diminished severity of rat EAE by enhancing immu-noregulatory\/protective properties of spinal cord microglia. Neurobiol. Dis., 134.","DOI":"10.1016\/j.nbd.2019.104665"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/2042098612455357","article-title":"Topiramate and cognitive impairment: Evidence and clinical implications","volume":"3","author":"Mula","year":"2012","journal-title":"Ther. Adv. Drug Saf."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/561\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:30:13Z","timestamp":1759919413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":71,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["jcm14020561"],"URL":"https:\/\/doi.org\/10.3390\/jcm14020561","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}